Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
BACK TO LIST

Laboratory Report

Patient
Name: Andresen, , Helene,
DOB: 17-OCT-1939 (Age: 86)
Gender: female
Address:
Kristiansenberget 2
0172 Sørensen (Norway)
ID: 3450-170343-2 (ECI)
Report
Date: 15-OCT-2017
Laboratory
dr Ample, Ex
Laboratoire Central Européenne
Boulevard du Jardin Botanique 32
1000 Brussels (Belgium)
Requested by
Oslo universitetssykehus (Ullevål)
0155 Oslo (Norway)
Specimen
Collected: 14-OCT-2017

Chemistry

Test 15-OCT-2017 Reference Range Unit
Hemoglobin A1c/Hemoglobin.total in Blood 5.9 4.5 - 6.4 %
Glucose [Mass/volume] in Blood 78.6 70 - 140 mg/dL
Urea nitrogen [Mass/volume] in Blood 17.3 7 - 25 mg/dL
Creatinine [Mass/volume] in Blood 0.6 0.6 - 1.1 mg/dL
Calcium [Mass/volume] in Blood 10.0 8.6 - 10.4 mg/dL
Sodium [Moles/volume] in Blood 136.1 135 - 145 mmol/L
Potassium [Moles/volume] in Blood 4.3 3.5 - 5.3 mmol/L
Chloride [Moles/volume] in Blood 108.0 98 - 108 mmol/L
Carbon dioxide, total [Moles/volume] in Blood 23.0 22 - 32 mmol/L

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
All measured laboratory values are within normal limits for this patient"s age and sex. There is no evidence of acute or chronic metabolic, renal, or electrolyte disturbances. Glycemic control appears adequate. No laboratory abnormalities detected at this time. Recommend continued routine monitoring as clinically indicated.